Adenosine deaminase deficiency
From Biocrawler, the free encyclopedia.
Adenosine deaminase deficiency, or ADA deficiency, is an inherited immunodeficiency syndrome accounting for about 25% of all cases of severe combined immunodeficiency (SCID).
This disease is due to a lack of the enzyme adenosine deaminase coded for by a gene on chromosome 20. There is an accumulation of dATP, which causes an increase in S-adenosylhomocysteine; both substances are toxic to immature lymphoid cells, so fail to reach maturity. As a result, the immune system of the afflicted person is severely compromised or completely lacking.
The enzyme adenosine deaminase is important for purine metabolism.
[edit]
Treatment
- bone marrow transplant
- gene therapy (efforts halted due to increased incidence of leukemia)
- ADA enzyme in PEG vehicle
[edit]
External link
 | This medical article is a stub. You can help Biocrawler by expanding it (http://www.biocrawler.com/w/index.php?title=Adenosine_deaminase_deficiency&action=edit). |
